en
Scientific article
English

Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project

Published inCancer epidemiology, vol. 38, no. 6, p. 670-678
Publication date2014
Abstract

Kaposi sarcoma (KS) is a virus-related malignancy which most frequently arises in skin, though visceral sites can also be involved. Infection with Kaposi sarcoma herpes virus (KSHV or HHV-8) is required for development of KS. Nowadays, most cases worldwide occur in persons who are immunosuppressed, usually because of HIV infection or as a result of therapy to combat rejection of a transplanted organ, but classic Kaposi sarcoma is predominantly a disease of the elderly without apparent immunosuppression. We analyzed 2667 KS incident cases diagnosed during 1995-2002 and registered by 75 population-based European cancer registries contributing to the RARECARE project. Total crude and age-standardized incidence rate was 0.3 per 100,000 per year with an estimated 1642 new cases per year in the EU27 countries. Age-standardized incidence rate was 0.8 per 100,000 in Southern Europe but below 0.3 per 100,000 in all other regions. The elevated rate in southern Europe was attributable to a combination of classic Kaposi sarcoma in some Mediterranean countries and the relatively high incidence of AIDS in several countries. Five-year relative survival for 2000-2002 by the period method was 75%. More than 10,000 persons were estimated to be alive in Europe at the beginning of 2008 with a past diagnosis of KS. The aetiological link with suppressed immunity means that many people alive following diagnosis of KS suffer comorbidity from a pre-existing condition. While KS is a rare cancer, it has a relatively good prognosis and so the number of people affected by it is quite large. Thus it provides a notable example of the importance of networking in diagnosis, therapy and research for rare cancers.

Citation (ISO format)
STILLER, C A et al. Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project. In: Cancer epidemiology, 2014, vol. 38, n° 6, p. 670–678. doi: 10.1016/j.canep.2014.09.009
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1877-7821
543views
0downloads

Technical informations

Creation12/15/2014 3:28:00 PM
First validation12/15/2014 3:28:00 PM
Update time03/14/2023 10:36:27 PM
Status update03/14/2023 10:36:26 PM
Last indexation01/16/2024 3:38:02 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack